Serum vasopressin concentrations during orthotopic liver transplantation.
暂无分享,去创建一个
M. Keegan | J. Findlay | B. Gali | B. Harrison | D. Plevak | D. Brown | D. Brown
[1] T. Berl,et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. , 2006, The New England journal of medicine.
[2] J. Peters,et al. The Vasopressin System: Physiology and Clinical Strategies , 2006, Anesthesiology.
[3] V. Arroyo,et al. New treatments of hepatorenal syndrome. , 2006, Seminars in liver disease.
[4] J. Roth. The use of vasopressin bolus to treat refractory hypotension secondary to reperfusion during orthotopic liver transplantation. , 2006, Anesthesia and analgesia.
[5] R. Moreau,et al. The use of vasoconstrictors in patients with cirrhosis: Type 1 HRS and beyond , 2006, Hepatology.
[6] R. MacLaren,et al. Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] W. Voelckel,et al. Vasopressin during uncontrolled hemorrhagic shock: less bleeding below the diaphragm, more perfusion above. , 2005, Anesthesia and analgesia.
[8] R. Setlur,et al. Vasopressin in hemorrhagic shock. , 2005, Anesthesia and analgesia.
[9] V. Wenzel,et al. Arginine vasopressin as a rescue vasopressor agent in the operating room , 2005, Current opinion in anaesthesiology.
[10] T. Haas,et al. Employing vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock , 2005, Der Anaesthesist.
[11] R. Busuttil,et al. Surgical advances in liver and bowel transplantation. , 2004, Anesthesiology clinics of North America.
[12] K. Walley,et al. Vasopressin in the ICU , 2004, Current opinion in critical care.
[13] C. Hogue,et al. Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol. , 2004, Anesthesia and analgesia.
[14] C. Kill,et al. Successful Treatment of Severe Anaphylactic Shock with Vasopressin , 2004, International Archives of Allergy and Immunology.
[15] W. Voelckel,et al. Treatment of Uncontrolled Hemorrhagic Shock After Liver Trauma: Fatal Effects of Fluid Resuscitation Versus Improved Outcome After Vasopressin , 2004, Anesthesia and analgesia.
[16] Mitchell M. Levy,et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.
[17] D. Landry,et al. Vasopressin deficiency in the syndrome of irreversible shock. , 2003, The Journal of trauma.
[18] W. Voelckel,et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs* , 2003, Critical care medicine.
[19] W. Voelckel,et al. Vasopressin, but Not Fluid Resuscitation, Enhances Survival in a Liver Trauma Model with Uncontrolled and Otherwise Lethal Hemorrhagic Shock in Pigs , 2003, Anesthesiology.
[20] P. Thuluvath,et al. A vasopressin receptor antagonist (VPA‐985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo‐controlled trial , 2003, Hepatology.
[21] D. Rockey,et al. Terlipressin in acute oesophageal variceal haemorrhage , 2003, Alimentary pharmacology & therapeutics.
[22] W. Jiménez,et al. Clinical need for antidiuretic hormone antagonists in cirrhosis , 2003, Hepatology.
[23] C. Selzman,et al. Vasopressin in the cardiac surgery intensive care unit. , 2002, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[24] R. Moreau,et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. , 2002, Gastroenterology.
[25] D. Chittock,et al. Beneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock , 2002, Anesthesiology.
[26] K. Walley,et al. Physiology of vasopressin relevant to management of septic shock. , 2001, Chest.
[27] R. Townsend,et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. , 1999, The Journal of trauma.
[28] Y. Baruch,et al. Low‐dose vasopressin restores diuresis both in patients with hepatorenal syndrome and in anuric patients with end‐stage heart failure , 1999, Journal of internal medicine.
[29] M. Oz,et al. Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[30] P. T. Overand,et al. Vasopressin for the treatment of refractory hypotension after cardiopulmonary bypass. , 1998, Anesthesia and analgesia.
[31] M. Oz,et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. , 1997, Circulation.
[32] M. Oz,et al. Vasopressin deficiency contributes to the vasodilation of septic shock. , 1997, Circulation.
[33] F. Zegher,et al. Anterior pituitary function during critical illness and dopamine treatment , 1996 .
[34] H. Geiger,et al. Perioperative Care of the Liver Transplant Patient: Part 1 , 1994, Anesthesia and analgesia.
[35] P. Daloze,et al. Vasopressin use in human liver transplantation. , 1987, Transplantation proceedings.
[36] W. Jiménez,et al. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. , 2000, Journal of hepatology.